No Profit in Sight for Canopy Growth Corp. (TSX:WEED)

Investors have grown tired of waiting for Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) to deliver. With the way things are going, it is better to hold off buying the stock until the company shows strength and profit.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

When is the profit coming? This question is directed to cannabis producers who promised investors a rose garden. The silver lining is a growth of about U.S$16.9 billion. Even Canopy Growth Corp. (TSX:WEED)(NYSE:CGC), the most well-known cannabis brand, couldn’t provide a definitive answer.

The legal cannabis market, particularly recreational pot sales, is expected to turn in enormous revenues. But up to now there is uncertainty in profitability. Just like chief rival Aurora Cannabis (TSX:ACB)(NYSE:ACB), the presumed largest producer, Canopy Growth is losing big time instead of earning.

Recap of 2018 milestones

Constellation Brands (NYSE:STZ) infused U.S$4.1 billion in the cannabis behemoth — a significant milestone. The move of the Corona beer maker bolsters the confidence that Canopy Growth has long-term growth potential. The money would be used to expand capacity and infiltrate new markets.

The company acquired Hiku Brands for $269 million for the purpose of adding another well-known brand to the company’s product portfolio. Canopy defended the purchase, claiming that it was necessary, although they lost headway as profits will not be realized anytime soon.

Canopy Growth believes that establishing a footprint in the U.S. is vital. Hence, the $425 million acquisition of Colorado-based research company Ebbu followed. The company is anticipating the federal government would soon legalize weed. It’s better to develop relationships in the U.S. market before that happens.

Waiting game

Canopy Growth will eventually realize a recurring profit from the major actions taken in 2018. But anxious shareholders might have to wait longer by maybe two to three years. Until then, the waiting game will persist. Early investors admit investing too soon. Some contend that the entry point should be cheaper than the current price of $56.73.

The erratic trading volume might indicate that investors are avoiding the cannabis space for now. It began as a crazy gold rush, and then turned into a scramble for the exits. Obviously, the marijuana industry is having problems with valuations. The very low profit margin is also a deal breaker.

Many analysts couldn’t even go around the valuation or justify it. To them, valuations in the cannabis space are astronomical. Maybe people are waiting for the U.S. to finally legalize the sector so serious valuation can begin. By then, industry followers might be able to assess future margins and determine earnings.

Canopy Growth will definitely lead the cannabis industry because of its size and scale, but that’s for the long run. Since earnings are purely speculative, as it’s still a risky investment today. Maintaining the current price level is doubtful, as CGC dropped again by 3.87% from the previous close.

Investors can’t help it but be reminded of the dot.com bubble in 1999. There are indeed striking similarities. Many lost hard-earned money from stocks that are total craps shoots. Down the road, consolidation in the industry is not far-fetched. Canopy Growth will be one of the fewer names that will remain.

Bottom line

Canopy Growth is the real thing, but when? The best advice, for now, is to wait for the company to show strength before you invest.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.    

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »